ClinicalTrials.gg
Not yet recruitingNCT07550439Updated Apr 24, 2026

Effect of World Health Organization Labour Care Guide On Reducing Cesarean Section Rates

An interventional study of WHO Labour Care Guide and Partogram in Labour, sponsored by Pak Emirates Military Hospital. Not yet recruiting. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Pak Emirates Military Hospital · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
174
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

After taking informed consent for participation in the study, all selected cases will be divided into two groups by lottery method. In group A, patients will receive care using WHO Labour Care Guide while in group B, patients will be monitored using WHO partograph.

Read the detailed description

After approval from ethical review committee, total 174 women presenting in the inpatient Department of Obstetrics \& Gynaecology, Pak Emirates Military Hospital, Rawalpindi, fulfilling the inclusion criteria will be selected. Informed consent will be taken from each woman. Age, gestational age, parity, height, weight and BMI will be noted. After taking informed consent for participation in the study, all selected cases will be divided into two groups by lottery method. In group A, patients will receive care using WHO Labour Care Guide while in group B, patients will be monitored using WHO partograph. Cesarean section will be noted in both groups. This all data including demographic data will be recorded on a specially designed proforma

02

Conditions studied

  • Labour

Keywords

  • Labour Care Guide
03

In context

Lead sponsor

Pak Emirates Military Hospital is the lead sponsor of 24 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All pregnant women in active phase of labour (>5cm cervical dilatation) and gestational age of 37 weeks to 41 completed weeks (as assessed on LMP).

Previous no caesarean section. Age 18-40 years. Both primiparous and multiparous. Both booked and unbooked.

Exclusion criteria

Exclusion Criteria:

Women with chronic hypertension (BP >140/90 mmHg on 2 consecutive occasions). Pregnancy induced Hypertension: women with no history of hypertension (blood pressure >140/90 mmHg on 2 consecutive occasions) and diagnosed in pregnancy.

Gestational Diabetes mellitus: women with no history of diabetes mellitus (FBS >110 mg/dl on 2 consecutive occasions) and diagnosed in pregnancy.

Women who had a caesarean section in the latent phase of labour.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
174 participants (estimated)

Study arms

  • Experimental
    Group A

    In group A, patients will receive care using WHO Labour Care Guide.

    Other: WHO Labour Care Guide

  • Placebo comparator
    Group B

    In group B, patients will be monitored using WHO partograph.

    Other: Partogram

Interventions

  • OtherWHO Labour Care Guide

    Labour will be monitored using WHO Labour care guide

  • OtherPartogram

    Labour will be monitored using partogram

06

What researchers measure

Primary outcomes

  1. Frequency of Cesarean Section

    To determine the frequency of caesarean section between World Health Organization Labour Care Guidelines versus partograph monitoring of labour.

    Time frame: 24 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2026; primary completion for Nov 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 19, 2026
First posted
Apr 24, 2026
StartEst.
May 2026
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
Apr 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07550439
Lead sponsor
Pak Emirates Military Hospital
Responsible party
Salma Nisar (Senior Registrar, Pak Emirates Military Hospital) — Principal investigator
First posted
Apr 24, 2026
Start date
May 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 24, 2026

Study contacts

Dr Sana Murtaza, MBBS
Contact
sanamurtaza093@gmail.com
+92 333 666188 ext. +92
Salma Nisar, MBBS, FCPS
principal investigator · Pak Emirates Military Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion